Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 07:34 am Sale |
2023-12-31 | 13G | BrainsWay Ltd. BWAY |
RTW INVESTMENTS LP | 0 0.000% |
-3,204,762 (Position Closed) |
Filing History |
| 2024-02-14 07:32 am Sale |
2023-12-31 | 13G | Apyx Medical Corporation APYX |
RTW INVESTMENTS LP | 1,025,963 3.000% |
-2,372,316 (-69.81%) |
Filing History |
| 2024-02-14 07:31 am Sale |
2023-12-31 | 13G | Adicet Bio, Inc. ACET |
RTW INVESTMENTS LP | 4,134,631 9.600% |
-106,841 (-2.52%) |
Filing History |
| 2024-02-14 07:29 am Sale |
2023-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
RTW INVESTMENTS LP | 0 0.000% |
-2,458,750 (Position Closed) |
Filing History |
| 2024-02-14 07:28 am Purchase |
2023-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS |
RTW INVESTMENTS LP | 3,152,341 9.500% |
604,216 (+23.71%) |
Filing History |
| 2024-02-14 07:26 am Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
RTW INVESTMENTS LP | 4,489,596 9.500% |
1,509,114 (+50.63%) |
Filing History |
| 2024-02-14 07:13 am Purchase |
2023-12-31 | 13G | PTC Therapeutics, Inc. PTCT |
RTW INVESTMENTS LP | 7,423,970 9.800% |
1,808,583 (+32.21%) |
Filing History |
| 2024-02-14 07:12 am Purchase |
2023-12-31 | 13G | Exagen Inc. XGN |
RTW INVESTMENTS LP | 1,504,602 8.800% |
140,266 (+10.28%) |
Filing History |
| 2024-02-14 07:12 am Sale |
2023-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
RTW INVESTMENTS LP | 0 0.000% |
-3,643,114 (Position Closed) |
Filing History |
| 2024-02-14 07:11 am Purchase |
2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW INVESTMENTS LP | 9,196,186 9.990% |
3,454,247 (+60.16%) |
Filing History |
| 2024-02-14 07:10 am Sale |
2023-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST |
RTW INVESTMENTS LP | 3,354,825 9.990% |
-960,277 (-22.25%) |
Filing History |
| 2024-02-14 07:10 am Purchase |
2023-12-31 | 13G | 89bio, Inc. ETNB |
RTW INVESTMENTS LP | 5,578,931 6.000% |
5,578,931 (New Position) |
Filing History |
| 2024-02-14 07:09 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
RTW INVESTMENTS LP | 5,197,019 8.700% |
5,197,019 (New Position) |
Filing History |
| 2024-02-14 07:08 am Purchase |
2023-12-31 | 13G | Taysha Gene Therapies, Inc. TSHA |
RTW INVESTMENTS LP | 18,505,556 9.800% |
18,505,556 (New Position) |
Filing History |
| 2024-02-14 07:08 am Purchase |
2023-12-31 | 13G | ACADIA Pharmaceuticals Inc. ACAD |
RTW INVESTMENTS LP | 11,253,551 6.900% |
11,253,551 (New Position) |
Filing History |
| 2024-02-14 07:07 am Purchase |
2023-12-31 | 13G | UroGen Pharma Ltd. URGN |
RTW INVESTMENTS LP | 1,726,808 5.600% |
1,726,808 (New Position) |
Filing History |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Akero Therapeutics, Inc. AKRO |
RTW INVESTMENTS LP | 3,592,759 6.400% |
3,592,759 (New Position) |
Filing History |
| 2024-02-14 07:06 am Purchase |
2023-12-31 | 13G | Arvinas, Inc. ARVN |
RTW INVESTMENTS LP | 4,213,483 6.200% |
4,213,483 (New Position) |
Filing History |
| 2024-02-14 07:05 am Purchase |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW INVESTMENTS LP | 2,298,662 5.200% |
2,298,662 (New Position) |
Filing History |
| 2024-02-14 07:04 am Purchase |
2023-12-31 | 13G | GH Research PLC GHRS |
RTW INVESTMENTS LP | 3,327,129 6.400% |
3,327,129 (New Position) |
Filing History |